Structure-based drug design with equivariant diffusion models

Open Access
Authors
  • A. Schneuing
  • C. Harris
  • Y. Du
  • K. Didi
  • A. Jamasb
  • I. Igashov
  • W. Du
  • C. Gomes
  • T.L. Blundell
  • P. Lio
  • M. Welling
  • M. Bronstein
  • B. Correia
Publication date 12-2024
Journal Nature Computational Science
Volume | Issue number 4 | 12
Pages (from-to) 899-909
Organisations
  • Faculty of Science (FNWI) - Informatics Institute (IVI)
Abstract
Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods leverage structural data of drugs with their protein targets to propose new drug candidates. However, most existing methods focus exclusively on bottom-up de novo design of compounds or tackle other drug development challenges with task-specific models. The latter requires curation of suitable datasets, careful engineering of the models and retraining from scratch for each task. Here we show how a single pretrained diffusion model can be applied to a broader range of problems, such as off-the-shelf property optimization, explicit negative design and partial molecular design with inpainting. We formulate SBDD as a three-dimensional conditional generation problem and present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel ligands conditioned on protein pockets. Furthermore, we show how additional constraints can be used to improve the generated drug candidates according to a variety of computational metrics.
Document type Article
Language English
Published at https://doi.org/10.1038/s43588-024-00737-x
Downloads
Supplementary materials
Permalink to this page
Back